Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA

Clinical trial NCT04470804 · COMPLETED

Trial details

NCT number: NCT04470804
Sponsor: Bing Han
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pure Red Cell Aplasia, Acquired

Start date: 2020-07-01
Primary completion: 2022-07-30
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.